Characteristics of Ex Vivo expansion of endothelial progenitor cells

Abstract

The characteristics for the ex vivo expansion of the endothelial progenitor cells (EPCs) were explored. CD34⁺ cells were selected from umbilical cord blood mononuclear cells (MNC) by MiniMACS system, expanded under the same conditions as those for total MNC, coincubation of CD34⁺ and CD34⁻ from the same donor for EPCs. In addition, the effects of vessel endothelial growth factor (VEGF) and passage on cell differentiation, expansion kinetics and apoptosis were examined. EPCs were determined and quantified by immunocytochemistry and flow cytometry. The results showed that both coculture of CD34⁺ and CD34⁻ and total MNC led to a significant increase in the expansion of CD34⁺ cells as compared with CD34 enrichment (P<0.05). There was a tendency toward decreased apoptosis in cultures when early passage was performed immediately after cord like structures appeared. VEGF had no significant effect on apoptosis (P>0.05). These differentiated EPCs were positive for CD34⁺, von Willebrand factor (vWF), KDR, CD31 staining and phagocytized acetylated low-density lipoprotein (LDL). CD34⁺ cells accounted for (68.2±6.3) % of attaching (AT) cells at day 7 of culture. It was suggested the most efficient method to ex vivo expansion of EPCs was coculture of CD34⁺ and CD34⁻ or total MNC. Early passage makes cell apoptosis rate decrease. VEGF had no significant effect on ex vivo expansion of EPCs.

Keywords

endothelial progenitor cell / expansion / CD34⁺ / apoptosis

References

[1] NishikawaS. I., NishikawaS., HirashimaM., et al.. Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+cells at a diverging point of endothelial and hemopoietic lineages. Development, 1998, 125(9): 1747-1757

[2] GehlingU. M., ErgunS., SchumacherU., et al.. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95(10): 3106-3112

[3] AsaharaT., MuroharaT., SullivanA., et al.. isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275(5302): 964-967

[4] TraycoffC. M., OraziA., LaddA.C., et al.. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34⁺ cells. Exp Hematol, 1998, 7926(1): 53-62

[5] HladovecJ.. The role of endothelium in the pathogensis of vascular diseases. Cor Vasa, 1989, 31(6): 433-443

[6] PerkinsS., FleischmanR. A.. stromal cell progeny of murine bone marrow fibroblast colony-forming units are clonal endothelial-like cells that express collagen IV and laminin. Blood, 1990, 75(3): 620-625

[7] GeorgeF., BrissonC., PonceletP., et al.. Rapid isolation of human endothelial cells from whole blood using S-Endol monoclomal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost, 1992, 67(1): 147-153

[8] HeimfeldS., KalamaszD. F., FogartyB. L., et al.. Isolation and ex vivo expansion of CD34⁺ cell from cord blood using dextran sedimentation and avidin column selection. Blood Cells, 1994, 20(2–3): 397-403

[9] YeeG. C.. The future of cell therapy. Pharmacotherapy, 1996, 16(3): 109S-115S

[10] DurandB., EddlemanK., MigliaccioA.R., et al.. long-term generation of colony-forming cells (CFC) from CD34⁺ human umbilical cord blood cells. Leuk Lymphoma, 1993, 11(3–4): 263-273

[11] ReyesM., DudekA., JahagirdarB., et al.. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest., 2002, 109(3): 337-346

[12] SoloveyA., LinY., BrowneP., et al.. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med, 1997, 337(22): 1584-1590